Misplaced Pages

Aubrey de Grey: Difference between revisions

Article snapshot taken from Wikipedia with creative commons attribution-sharealike license. Give it a read and then ask your questions in the chat. We can research this topic together.
Browse history interactively← Previous editNext edit →Content deleted Content addedVisualWikitext
Revision as of 14:04, 6 December 2004 editAndrewwall (talk | contribs)52 editsmNo edit summary← Previous edit Revision as of 13:04, 8 January 2005 edit undoLexor (talk | contribs)Extended confirmed users12,806 edits Apply some light NPOVing to article, remove duplicate linksNext edit →
Line 1: Line 1:
] ]


'''Aubrey de Grey''' (born 1963) is a pioneering ] at the ] in ] who is currently working to expedite the development of a true cure for human aging, a medical goal he refers to as ] (senescence is a fancy word for aging). De Grey is also an outspoken supporter of radical ]. '''Aubrey de Grey''' (born 1963) is a ] at the ] in ] who is currently working to expedite the development of a cure for human aging, a medical goal he refers to as ] (] means aging). De Grey is also an outspoken supporter of radical ].


Prior to his work as a ], de Grey was formally trained in ]—a discipline that provided him with insight into the human aging problem and ] in particular. He argues that the fundamental knowledge necessary to develop effective anti-aging medicine mostly exists today. To that end he works to identify and promote specific technological approaches to the reversal of various aspects of aging and for the more proactive and urgent approaches to extending the healthy human lifespan. Prior to his work as a ], de Grey was formally trained in ] and ]. He argues that the fundamental knowledge necessary to develop effective anti-aging medicine mostly exists today. To that end he works to identify and promote specific technological approaches to the reversal of various aspects of aging and for the more proactive and urgent approaches to extending the healthy human lifespan.


De Grey's current work at Cambridge centers around a detailed plan called '''Strategies for Engineered Negligible Senescence''' (SENS) which is aimed at preventing age-related physical and cognitive decline. He is also the co-founder and chief scientist of the ], a contest designed to accelerate research into effective life extension interventions by awarding prizes to researchers who extend the lifespan of mice to unprecedented lengths. ], De Grey's current work at Cambridge centered around a detailed plan called '''Strategies for Engineered Negligible Senescence''' (SENS) which is aimed at preventing age-related physical and cognitive decline. He is also the co-founder and chief scientist of the ], a contest designed to accelerate research into effective life extension interventions by awarding prizes to researchers who extend the lifespan of mice to unprecedented lengths.

==Related articles==
* ]<br>
* ]<br>
* ]


==External links== ==External links==
* <br> *
* *
* *

Revision as of 13:04, 8 January 2005

File:De grey.jpg
Aubrey de Grey

Aubrey de Grey (born 1963) is a biogerontologist at the University of Cambridge in England who is currently working to expedite the development of a cure for human aging, a medical goal he refers to as engineered negligible senescence (senescence means aging). De Grey is also an outspoken supporter of radical life extension.

Prior to his work as a biologist, de Grey was formally trained in computer science and cellular biology. He argues that the fundamental knowledge necessary to develop effective anti-aging medicine mostly exists today. To that end he works to identify and promote specific technological approaches to the reversal of various aspects of aging and for the more proactive and urgent approaches to extending the healthy human lifespan.

As of 2005, De Grey's current work at Cambridge centered around a detailed plan called Strategies for Engineered Negligible Senescence (SENS) which is aimed at preventing age-related physical and cognitive decline. He is also the co-founder and chief scientist of the Methuselah Mouse Prize, a contest designed to accelerate research into effective life extension interventions by awarding prizes to researchers who extend the lifespan of mice to unprecedented lengths.

External links

Category: